By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Purdue Pharmaceuticals L.P. 

4701 Purdue Drive

Wilson  North Carolina  27893  U.S.A.
Phone: 252-265-1900 Fax: 252-243-2533


Purdue Pharmaceuticals L.P. is a 200,000-square-foot, state-of-the-art pharmaceutical manufacturing, packaging, and distribution facility that produces oral solid dosage tablets and also distributes oral liquids and sterile injectibles for Purdue Pharma L.P., an independent associated company headquartered in Stamford, CT. These privately held companies, founded by physicians and focused on meeting the needs of healthcare providers and the patients in their care, are dedicated to finding, developing, and bringing to market new medicines and related products that improve health outcomes. The companies have long been known for their pioneering research on persistent pain, a principal cause of human suffering.

Purdue Pharma also has a growing line of non-prescription products including laxatives, microbicides, and nutraceuticals. The company is dedicated to serving the evolving needs of healthcare providers, patients, and caregivers with prescription and non-prescription medicines. A commitment to innovation and caring spans every aspect of the organization, from discovering and launching new medicines to demonstrating their medical value.

Purdue Pharma has led the battle against inadequate treatment of pain by developing sustained-release medications to manage pain. Its sales, marketing, and medical education professionals provide the healthcare community with comprehensive educational materials and programs relating to pain management.

In 1993, Purdue Pharma established Partners Against PainĀ® as a resource to help patients, caregivers, and healthcare professionals advance standards of pain care and alleviate unnecessary suffering through education and advocacy. Purdue has also assumed a leading role in addressing the serious public health problem of prescription drug abuse, supporting programs intended to help stem abuse.

Key Statistics

Ownership: Private

Web Site: Purdue Pharma L.P.
Employees: 195


Company News
Purdue Pharma L.P. Names Gail Cawkwell, MD, PhD, Vice President Of Medical Affairs 11/17/2014 12:03:56 PM
Purdue Pharma L.P. Commercially Launches Recently Approved 7.5 Mcg/Hour Dosage Strength Of ButransĀ® (Buprenorphine) Transdermal System CIII 10/9/2014 7:55:44 AM
Purdue Pharma L.P. Names Susie Robinson Vice President of Human Resources 9/15/2014 9:29:01 AM
FDA To Expedite Review Of Purdue Pharma L.P. Once-Daily Painkiller Tablet 7/8/2014 8:42:42 AM
Purdue Pharma L.P. Presents Data From Research Studies At American Pain Society 33rd Annual Scientific Meeting 4/29/2014 9:47:51 AM
Zogenix, Inc. (ZGNX) Falls As Rival Purdue Pharma L.P. Announces Positive Phase 3 Trial Of Abuse-Resistant Pill 3/12/2014 7:14:26 AM
Purdue Pharma L.P. Names Mark Timney President And Chief Executive Officer 1/27/2014 6:44:41 AM
Purdue Pharma L.P. Announces Resolution Of OxyContin® (Oxycodone HCl Controlled-Release) Tablets CII Patent Lawsuit With IMPAX Laboratories, Inc. (IPXL) 12/3/2013 11:46:13 AM
FDA Accepts For Review Purdue Pharma L.P.'s New Drug Application For Targiniq™ ER (oxycodone HCl/naloxone HCL Controlled-Release) Tablets CII 11/26/2013 8:49:24 AM
Purdue Pharma L.P. to Present Data pn Long-Term Analgesic Efficacy of Opioid Therapy 9/6/2013 9:12:35 AM